Welcome, Guest. Please login or register.
April 19, 2021, 07:51:55 am

Login with username, password and session length

 

Members
Stats
  • Total Posts: 308
  • Total Topics: 164
  • Online Today: 12
  • Online Ever: 518
  • (January 21, 2020, 05:24:49 pm)
Users Online
Users: 0
Guests: 5
Total: 5

Welcome!

Welcome to the Cancer Health Forums, a round-the-clock discussion area for people who have any type of cancer, their friends and family and others with questions about living with cancer. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Cancer Health Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Update: Hallmarks Of Cancer  (Read 1120 times)

Offline danialthomas

  • Newbie
  • *
  • Posts: 36
  • Doctor Of Osteopathy
    • View Profile
    • Thomas Health Blog
Update: Hallmarks Of Cancer
« on: December 09, 2020, 04:01:30 pm »
Recently, I wrote about the hallmarks of cancer. Tumors are well organized structures, and they follow a strict set of rules. Scientists have identified universal pillars or traits of human malignancy that allow it to grow and spread. Collectively, these are called the “hallmarks” of cancer, and therapeutically targeting them as many as possible can enhance conventional treatment and improve your chances for achieving remission and long-term survival.
On December 3, 2020, an article entitled “Targeting the pH Paradigm at the Bedside: A Practical Approach” was published in the International Journal of Molecular Sciences. The author of the article provided compelling evidence that we should expand the list of hallmarks of cancer from ten to eleven (see below). What is important about #11 on the list, is that the reversal of pH is not dependent on lactic acid production from the Warburg effect and takes place before the Warburg effect is functionally operative. Furthermore, lactic acid is not the only cause of acidity, as carbon dioxide is equally important.


1. Resistance to apoptosis (cell death): Apoptosis is a protective mechanism by which cells are programmed to die if they become damaged and potentially harmful. Cancer cells bypass this mechanism. Therapeutic target: Activate caspase protease enzymes and downregulate TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) protein.

2. Replicative immortality: Normal cells die after a finite number of cell divisions. Cancer cells bypass this limit and are capable of infinite divisions (immortality) and sustained proliferation. Therapeutic target: Deactivate telomerase and destabilize telomeres.

3. Evading immune attack: Cytotoxic T-cells (CTCs) and natural killer (NK) cells are the main anti-cancer immune cells. CTCs and NK cells can be rendered impotent by immunosuppressive cancer-associated fibroblasts (CAFs), tumor-associated macrophages (TAMs), and T-regulatory cells (Tregs) in the tumor microenvironment. Therapeutic targets: Increase the number and competency of CTCs and NK cells, reprogram CAFs and TAMs, and suppress the activity of Tregs.

4. Genetic instability: DNA is damaged thousands of times during each cell division. That damage must be repaired, including in cancer cells. Otherwise, the cells may die due to this damage. Therapeutic target: Inhibit the enzyme known as PARP (poly ADP-ribose polymerase) used by cells to repair damage to their DNA.

5. Altered metabolism and deregulated cellular energetics: The metabolism of cancer cells and the tumor stroma is different from normal cells. Cancer and stromal cells use alternative metabolic pathways to generate energy and building blocks to fuel malignant growth and spread. Therapeutic targets: Disable metabolic coupling between cancer cells and stromal cells and deprive cancer of the high-energy nutrients it needs (i.e., glucose, glutamine, fatty acids, ketones, and lactate).

6. Inflammation: Local or systemic inflammation induced by the tumor microenvironment acts as a major driver of cancer. Therapeutic target: Suppress local and systemic inflammation.

7. Tumor hypoxia and angiogenesis: A growing tumor soon outstrips its oxygen and blood supply and needs to grow new blood vessels to deliver oxygen and nutrients. To orchestrate this, cancer cells boost the production of growth factors that stimulate angiogenesis. Therapeutic target: Inhibit hypoxia-inducible factors (HIFs) and vascular endothelial growth factor (VEGF).

8. Invasion and metastasis: Cancer cells invade surrounding tissue and spread (metastasize) to distant sites in the body. Therapeutic targets: Inhibit HGF (hepatocyte growth factor), c-Met (mesenchymal-epithelial transition factor), lymphangiogenesis (growth of new lymph vessels), and exosome release.

9. Sustained proliferative signaling: Cancer cells can permanently activate signaling pathways that promote excessive growth. It’s like the accelerator pedal is stuck. Therapeutic targets: Inhibit cancer-promoting MDM2 oncogene and block epidermal growth factor receptor (EGFR).

10. Evading growth suppressors: To prevent overcrowding, normal cells have mechanisms that prevent excess cell growth and division. In cancer cells, tumor suppressor proteins are altered so they don’t prevent cell division. It’s like the brakes don’t work. Therapeutic targets: Unmutate and activate the cancer-suppressor p53 gene and inhibit cyclin-dependent kinases (CDKs).

11. Reversal of the pH gradient: In normal cells, the intracellular environment is more acidic (lower pH), and the extracellular environment is more alkaline (higher pH). In cancer cells, this is reversed, where the intracellular environment is more alkaline, and the extracellular environment is more acidic. This condition enables tumors to grow and spread, resist the effects of chemotherapy, and inhibit immune attack. Therapeutic targets: Decrease the pH of the intracellular environment of cancer cells and increase the pH of the extracellular environment by inhibiting membrane carbonic anhydrases and monocarboxylate transporters.

If you or a loved one are being treated for cancer, to improve your/their chances of beating the disease, be sure to ask the oncologist how many of the above hallmarks of cancer he/she is targeting. If it is not all eleven hallmarks, to address any that are being ignored, I urge to you seek the services of a physician who possesses a deep understanding of the complex biology of cancer and is educated and experienced in integrative therapies. (Please do not contact my office as my practice is full and I am unable to accept new patients.)


Dr. Daniel Thomas, DO, MS
Mount Dora, Florida, USA
Located in Mount Dora, Florida, Dr. Thomas is one of the most educated, experienced, and innovative physicians in North America. Over the past 30 years, he has helped people throughout the United States and Canada to prevent and overcome disease, improve their health, slow aging, and increase their lifespan. As an active translational researcher, Dr. Thomas has spent over 35,000 hours poring over the latest scientific discoveries and translating max. discoveries into promising theories

 


© 2021 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.